PPARγ激动剂Pioglitazone对神经病理性疼痛大鼠小胶质细胞线粒体氧化应激的影响

Effect of PPARγ agonist Pioglitazone on microglia mitochondrial oxidative stress in neuropathic pain rats

  • 摘要: 目的:探讨过氧化物酶体增殖物激活受体-γ(PPARγ)激动剂吡格列酮(Pioglitazone)对神经病理性疼痛大鼠痛行为学及对脊髓背角小胶质细胞线粒体氧化应激的影响。方法:将40只SD雄性大鼠按随机数字表法分为4组:假手术(sham)+溶剂二甲基亚砜组(DMSO,S+D组)、sham+Pioglitazone组(S+P组)、坐骨神经结扎(CCI)+溶剂DMSO组(I+D组)和CCI+Pioglitazone组(I+P组)。采用CCI术建立神经病理性疼痛模型,CCI术后第7~14天鞘内注射相应的药物。于术前(T0)及术后第3天(T1)、第7天(T2)、第14天(T3)检测各组大鼠机械缩足阈值(PWMT)和热缩足反射潜伏期(PWTL),并取术后第14天大鼠脊髓腰膨大部标本,通过免疫荧光技术观察小胶质细胞活化情况;透射电镜观察小胶质细胞线粒体超微结构的损伤;蛋白免疫印迹(western blotting)检测线粒体生物发生关键调控因子NRF1表达;实时荧光定量PCR技术(RT-qPCR)检测线粒体DNA(mtDNA)含量;氧化物阴离子探针检测活性氧(ROS)水平;检测各组超氧化物歧化酶(SOD)活性以及丙二醛(MDA)水平;酶联免疫吸附法(ELISA)检测炎性因子IL-1β、IL-6、TNF-α的表达。结果:与I+D组相比,I+P组给药后T2~T3时PWMT、PWTL均明显升高(P<0.05),脊髓背角小胶质细胞活化减少(P<0.05),透射电镜显示线粒体结构改善,活性氧ROS和MDA含量降低(P<0.05),SOD酶活性增加(P<0.05),线粒体NRF1和mtDNA的表达增加(P<0.05),同时炎性因子IL-1β、IL-6、TNF-α表达水平降低(均P<0.05)。结论:鞘内注射Pioglitazone可缓解大鼠神经病理性疼痛,其机制可能与抑制小胶质细胞异常活化,保护小胶质细胞线粒体功能,降低氧化应激从而减轻炎症反应有关。

     

    Abstract: Objective: To investigate the effect of Peroxisome proliferator-activated receptor γ(PPARγ) agonist Pioglitazone on pain behavior and mitochondrial oxidative stress of spinal dorsal horn microglia in rats with neuropathic pain. Methods: Forty SD male rats were divided into four groups according to random number table method: sham operation(sham) + solvent dimethyl sulfoxide group(DMSO, S + D group), sham + Pioglitazone group(S+P group), sciatic nerve ligation(CCI)+solvent DMSO group(I+D group) and CCI+Pioglitazone group(I+P group). The neuropathic pain model was established by CCI surgery, and corresponding drugs were injected intrathecally on the 7th to 14th day after CCI. The paw withdrawal mechanical threshold(PWMT) and paw withdrawal thermal latency(PWTL) of rats in each group were measured before operation(T0) and on the 3rd(T1),7th(T2) and 14th(T3) day after operation. The spinal cord and lumbar enlargement specimens of rats were taken on the 14th day after operation. The activation of microglia was observed by immunofluorescence technique. The mitochondrial damage of microglia was observed by transmission electron microscopy. The expression of NRF1,a key regulatory factor of mitochondrial biogenesis, was determined by western blotting. Mitochondrial DNA(mtDNA) content was detected by reverse transcription-quantitative polymerase chain reaction(RT-qPCR). The levels of reactive oxygen species(ROS) were detected by oxide anion probe. The activity of superoxide dismutase(SOD) and the level of malondialdehyde(MDA) in each group were detected. The expression of inflammatory factors IL-1β, IL-6 and TNF-α was detected by enzyme-linked immunosorbent assay(ELISA). Results: Compared with the I+D group, PWMT and PWTL in the I+P group were significantly increased at T2-T3 after administration(P<0.05), and the activation of spinal dorsal cornea microglia was decreased(P<0.05). Transmission electron microscopy showed that mitochondrial structure was improved, and the contents of ROS and MDA were decreased(P<0.05). SOD activity was increased(P<0.05), mitochondrial NRF1 and mtDNA expression was increased(P<0.05), and inflammatory factors IL-1β, IL-6 and TNF-α expression levels were decreased(all P<0.05). Conclusion: Intrathecal injection of Pioglitazone can alleviate neuropathic pain in rats, and its mechanism may be related to the inhibition of abnormal activation of microglia, protection of mitochondrial function of microglia, reduction of oxidative stress and thus reducing inflammation.

     

/

返回文章
返回